EU visit to vaccine plant under scrutiny over AstraZeneca delays

Name: EU visit to vaccine plant under scrutiny over AstraZeneca delays
Uploaded: 2021-02-10T19:03:19+00:00
Duration: P110S
Description: The site at Seneffe, south of Brussels, manufactures the active ingredient of AstraZeneca's COVID-19 vaccine.

Credit: euronews (in English)

Duration: 01:50s 10 Feb 2021 0 shares 4 views

EU visit to vaccine plant under scrutiny over AstraZeneca delays

The site at Seneffe, south of Brussels, manufactures the active ingredient of AstraZeneca's COVID-19 vaccine.

EU visit to vaccine plant under scrutiny over AstraZeneca delays

You might like